These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11258506)

  • 1. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients.
    Heldal E; Arnadottir T; Cruz JR; Tardencilla A; Chacon L
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):129-36. PubMed ID: 11258506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of resistance to anti-tuberculosis drugs: results of the 1998/99 national survey in Italy.
    Migliori GB; Fattorini L; Vaccarino P; Besozzi G; Saltini C; Orefici G; Iona E; Matteelli A; Fiorentini F; Codecasa LR; Casali L; Cassone A;
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):32-8. PubMed ID: 11931399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T; Yanai H; Rhiengtong D; Palittapongarnpim P; Nampaisan O; Supawitkul S; Uthaivorawit W; Mori T
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T; Ataç G; Güngör G; Törün I; Aksoy E; Gemci ; Tahaoglu K
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research and control of relapse tuberculosis cases].
    Yamagishi F; Toyota M
    Kekkaku; 2009 Dec; 84(12):767-8. PubMed ID: 20077861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance monitoring: combined rates may be the best indicator of programme performance.
    Van Deun A; Salim AH; Daru P; Das AP; Aung KJ; Hossain MA; Rigouts L; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):23-30. PubMed ID: 14974742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003.
    Ottmani SE; Zignol M; Bencheikh N; Laâsri L; Chaouki N; Mahjour J
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1367-72. PubMed ID: 17167954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.
    Anuradha B; Aparna S; Hari Sai Priya V; Vijaya Lakshmi V; Akbar Y; Suman Latha G; Murthy KJ
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):58-62. PubMed ID: 16466038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin.
    Gninafon M; Tawo L; Kassa F; Monteiro GP; Zellweger JP; Shang H; Lambregts K; Trébucq A
    Int J Tuberc Lung Dis; 2004 Oct; 8(10):1242-7. PubMed ID: 15527157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi.
    Harries AD; Nyirenda TE; Kemp JR; Squire BS; Godfrey-Faussett P; Salaniponi FM
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-1999.
    Crudu V; Arnadottir T; Laticevschi D
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):336-42. PubMed ID: 12729338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.